NCT06965894

Brief Summary

Hemiplegia (weakness or paralysis on one side of the body) often impacts the lower extremities, making it challenging for patients to walk or move their legs effectively. This study aims to explore the effects of pressure splints on the lower extremity movement and function in individuals who have experienced a stroke and suffer from hemiplegia. Pressure splints are specialized devices designed to support and enhance muscle function by applying gentle pressure to the affected limbs. Participants in this study will be randomly assigned to one of two groups: the Splint Group (SG) or the Control Group (CG). The duration of the intervention will be six weeks. During this period, all the participants will receive neurodevelopmental therapy. In the SG exercises will be done with the help of the lower extremity pressure splints while participants in the CG will join the exercises without any splint. This study is significant as it may lead to the development of new methods to enhance recovery for stroke patients and offer better rehabilitation options.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

May 13, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2026

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

April 30, 2025

Last Update Submit

May 14, 2025

Conditions

Keywords

StrokeRehabilitationGaitJohnstone SplintMotor Recovery

Outcome Measures

Primary Outcomes (4)

  • Lower Extremity Motor Function

    The improvement in motor function of the lower extremity will be assessed by Fugl-Meyer Assessment for Lower Extremity (FMA). The FMA is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 34.

    Through study completion, an average of 8 months

  • Balance

    The Berg Balance Scale (BBS) will be used to assess balance. This scale objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.

    Through study completion, an average of 8 months

  • Lower Extremity Strength

    The Five Times Sit to Stand Test will be used for the assessment of lower limb strength along with balance and postural control. Score is the amount of time it takes for an patient to transfer from a seated position to standing position and back to sitting five times.

    Through study completion, an average of 8 months

  • Mobility

    Mobility will be assessed by Timed Up and Go (TUG). TUG is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees.

    Through study completion, an average of 8 months

Secondary Outcomes (4)

  • Stroke Recovery

    Through study completion, an average of 8 months

  • Ambulation

    Through study completion, an average of 8 months

  • Independence

    Through study completion, an average of 8 months

  • Muscle Tone

    Through study completion, an average of 8 months

Study Arms (2)

Splint Group

EXPERIMENTAL

Participants in this group will receive a rehabilitation program including neurodevelopmental therapy and proprioceptive neuromuscular facilitation (PNF) techniques. In addition to the rehabilitation program, a Johnston pressure splint will be applied to the affected lower extremity during therapy sessions. The intervention aims to provide controlled pressure and support to improve motor recovery, balance, and gait in hemiplegic stroke patients.

Device: Johnston Pressure SplintOther: Rehabilitation Program

Control Group

ACTIVE COMPARATOR

Participants in this group will receive a rehabilitation program including neurodevelopmental therapy and proprioceptive neuromuscular facilitation (PNF) techniques without the pressure splint. This group will serve to compare the effects of standard rehabilitation alone versus rehabilitation combined with pressure splinting.

Other: Rehabilitation Program

Interventions

Application of a Johnston pressure splint to the lower extremity.

Splint Group

Rehabilitation program including neurodevelopmental therapy and proprioceptive neuromuscular facilitation (PNF) techniques.

Control GroupSplint Group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having hemiplegia because of stroke
  • Time since stroke: 1 month to 1 year
  • Ability to Participate (a score of \>24 on the Mini-Mental State Examination).
  • Being voluntary
  • Age between 50-80

You may not qualify if:

  • Severe Cognitive Impairment Other Neurological Disorders Severe Comorbidities or Spasticity on Lower Extremity Contraindications to Exercise Recurrent Stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monseigneur Cortbawi Hospital

Jounieh, Keserwan, 1200, Lebanon

RECRUITING

MeSH Terms

Conditions

HemiplegiaStroke

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Mansour Dib, Doctor

    Mgr Cortbawi Hospital

    STUDY CHAIR

Central Study Contacts

Çiçek Günday, Asst. Prof.

CONTACT

Ousama Maarbani, Physiotherapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

April 30, 2025

First Posted

May 11, 2025

Study Start

May 13, 2025

Primary Completion

January 13, 2026

Study Completion

February 1, 2026

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations